Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC N-[4-(4-amino-2-ethylimidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide | 532959-63-0 | MFCD30533308 | 99.9% | 361.5 g/mol | C17H23N5O2S | 25 MG
SDP

Catalog No. 5000215581
Encompass_Preferred

PF-4878691 is an orally active small-molecule toll-like receptor 7 (TLR7) agonist used in preclinical research to stimulate innate immune responses. It has reported antiviral activity against hepatitis C virus and is applied in oncology and infectious disease research models.

  • Orally active TLR7 agonist.
  • Stimulates innate immune responses, including interferon production.
  • Demonstrated antiviral activity against hepatitis C virus.
  • Suitable for preclinical in vitro and in vivo research.
  • High chemical purity for research applications.
  • For research use only; not for human or clinical use.

Catalog No. 50-002-15581 Supplier Medchemexpress LLC Supplier No. HY10017625MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PF-4878691 is an orally active small-molecule toll-like receptor 7 (TLR7) agonist used in preclinical research to stimulate innate immune responses. It has reported antiviral activity against hepatitis C virus and is applied in oncology and infectious disease research models.

  • Orally active TLR7 agonist.
  • Stimulates innate immune responses, including interferon production.
  • Demonstrated antiviral activity against hepatitis C virus.
  • Suitable for preclinical in vitro and in vivo research.
  • High chemical purity for research applications.
  • For research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.